EphA4, an ephrin receptor that also interacts with the VAPB MSPd (Lua et al., 2011; Tsuda et al., 2008), modifies pathogenesis in ALS patients and in a zebrafish model (Van Hoecke et al., 2012). This evidence concerns the gene VAPB and amyotrophic lateral sclerosis.